A Study to Collect Patient Data Collected Through Standard of Care Clinical Visits on the Subject of Hydronephrosis (Common Pediatric Urological Disorder that is Detected Prenatally, or Postnatal Infancy)
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 18-001873
Sponsor Protocol Number: 18-001873
About this study
The purpose of this research study is to contribute to an existing registry that was developed by Virginia Commonwealth University (VCU). The registry will warehouse data points for patients detected prenatally or postnatally with hydronephrosis.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Patients of age 18 to 65 will be asked to be in this study because they are pregnant and their fetus has hydronephrosis or if they have a child who has hydronephrosis.
- Mothers under 18 will not be enrolled.
- All children will be under the age of 6.
Exclusion Criteria:
- Anyone who doesn’t carry the hydronephrosis condition.
- Who denies consent.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Patricio Gargollo, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available